TickerFactsScreenerDevelopers

ACADIA PHARMACEUTICALS INC (ACAD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $21.17M2009: $18.12M2010: $6.85M2011: $6.89M2012: $57.90M2013: $11.71M2014: $61.85M2015: $102.14M2016: $163.62M2017: $69.42M2018: $134.76M2019: $189.68M2020: $326.03M2021: $147.44M2022: $114.85M2023: $188.66M2024: $319.59M2025: $177.69M$177.69M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$177.69M-44.4%
2024$319.59M+69.4%
2023$188.66M+64.3%
2022$114.85M-22.1%
2021$147.44M-54.8%
2020$326.03M+71.9%
2019$189.68M+40.8%
2018$134.76M+94.1%
2017$69.42M-57.6%
2016$163.62M+60.2%
2015$102.14M+65.1%
2014$61.85M+428.4%
2013$11.71M-79.8%
2012$57.90M+740.5%
2011$6.89M+0.6%
2010$6.85M-62.2%
2009$18.12M-14.4%
2008$21.17M—